Sun Pharma announces settlement of patent litigation for generic Revlimid in the US EP News Bureau Jun 22, 2021 Pursuant to the terms of the settlement, Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture…
Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene EP News Bureau Dec 11, 2020 Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited…
Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US EP News Bureau Sep 17, 2020 Celgene has agreed to provide Dr Reddy’s with a license to sell volume-limited amounts of generic lenalidomide capsules in the US…
